EYPT:NASDAQ
EyePoint Inc
3,23 $
arrow_downward
-1,22%(-0,040) 1D
3,25 $
arrow_upward
+0,62% (+0,020)bedtimeAfter hours
Closed: 1 қаз., 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EYPT...
Open
3,29 $
High
3,45 $
Low
3,23 $
Mkt. cap
278,47 млн
Avg. vol.
4,15 млн
Volume
2,86 млн
52-wk high
19,01 $
52-wk low
3,23 $
EPS
-3,74 $
Beta
1,63
Shares outstanding
86,21 млн
No. of employees
214
Open
3,29 $
High
3,45 $
Low
3,23 $
Mkt. cap
278,47 млн
Avg. vol.
4,15 млн
Volume
2,86 млн
52-wk high
19,01 $
52-wk low
3,23 $
EPS
-3,74 $
Beta
1,63
Shares outstanding
86,21 млн
No. of employees
214
News stories
From web sources and news partners
Reuters
·
16 минут бұрын
Australia's Sunrise Energy Metals plans US redomicile, primary Nasdaq listing
WTAQ
·
53 минут бұрын
Moderna to join Nasdaq 100, replacing Warner Bros Discovery
The Globe and Mail
·
10 минут бұрын
Kaplan Fox Encourages Investors of Fluence Energy, Inc. (NASDAQ: FLNC) to Contact the Firm to Learn About Their Legal Rights
MarketWatch
·
4 сағат бұрын
The stock market is anything but normal right now — and these charts show it
Profile
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems and nanotechnology to drug delivery.
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency. QinetiQ continues to be a strategic partner.
In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc. Wikipedia
About EyePoint Inc
CEO-
Employees214
Founded2000
HeadquartersWatertown, Массачусетс, Америка Құрама Штаттары
SectorPharmaceutical industry
Websiteeyepoint.bio